Yes, absolutely treat with benzathine penicillin G immediately
A pregnant patient with a reactive RPR screening test should be treated with benzathine penicillin G using the regimen appropriate for her stage of syphilis. This is the only effective treatment for preventing maternal transmission to the fetus and treating established fetal infection 1, 2.
Treatment Algorithm
Step 1: Confirm the diagnosis
- A reactive RPR in pregnancy should be considered active infection unless there is clear documentation of adequate prior treatment with appropriate serologic decline 1
- Do not delay treatment waiting for confirmatory treponemal testing
Step 2: Determine the stage of syphilis
The penicillin regimen depends on the stage:
For primary, secondary, or early latent syphilis:
- Benzathine penicillin G 2.4 million units IM as a single dose
- Consider a second dose of 2.4 million units IM one week later - some experts recommend this additional therapy for pregnant women, particularly those in the third trimester or with secondary syphilis 2, 3, 2
For late latent syphilis or syphilis of unknown duration:
- Benzathine penicillin G 2.4 million units IM weekly for 3 consecutive weeks (total 7.2 million units) 1
Step 3: Critical timing considerations
The evidence strongly suggests single-dose therapy may be insufficient. A prospective South African study found that one injection of 2.4 million units resulted in significantly worse outcomes compared to multiple doses: lower birth weight (2,748 vs 3,130g), 8.5-fold increased risk of prematurity, and 20.5-fold increased risk of perinatal mortality 4. Another study showed a strong protective trend with each additional dose received (adjusted OR 0.63 per dose for perinatal mortality) 5.
Treatment must provide treponemicidal coverage for more than 3 weeks before delivery - outcomes were comparable to no treatment when coverage was ≤3 weeks 4. This is especially critical for:
- Women presenting before 28 weeks gestation
- RPR titers >1:16
- Women who may deliver within 4 weeks of treatment
Special Circumstances
If penicillin allergy is reported:
There are no acceptable alternatives to penicillin in pregnancy 3. The patient must be:
- Skin tested to confirm true allergy
- Desensitized if allergy is confirmed
- Then treated with penicillin
Erythromycin and other macrolides cannot be relied upon to cure fetal infection and should not be used 3.
Monitoring and follow-up:
- Check RPR titers monthly during pregnancy 3
- Expect appropriate 4-fold decline for stage of disease
- Retreat if titers don't decline appropriately or rise 4-fold
- Perform fetal ultrasound if diagnosed in second half of pregnancy (don't delay treatment for this) 1
Warning about Jarisch-Herxheimer reaction:
Women treated in the second half of pregnancy risk premature labor and fetal distress from this reaction 2. Counsel them to seek immediate obstetric attention if they notice contractions or decreased fetal movements after treatment. However, this concern should never delay necessary treatment 2.
Common Pitfalls to Avoid
- Don't use single-dose therapy reflexively - while guidelines list it for early syphilis, the evidence suggests multiple doses improve outcomes, especially with high titers or early pregnancy presentation
- Don't accept "penicillin allergy" at face value - most reported allergies are not true IgE-mediated reactions; desensitization is mandatory if needed
- Don't delay treatment for confirmatory testing - treat based on reactive RPR in pregnancy
- Don't assume adequate treatment from history alone - verify documented treatment and appropriate serologic response
The FDA label confirms benzathine penicillin G is indicated for syphilis treatment, with reproduction studies showing no evidence of fetal harm, though it notes the drug should be used in pregnancy "only if clearly needed" 6 - which syphilis in pregnancy definitively is, given the catastrophic consequences of untreated maternal syphilis including stillbirth, congenital infection, and perinatal death 7, 8.